MoneyWorks4Me

Sanjivani Paranteral - Quaterly Results

24 Jul 2023 Evaluate
The Sales for the quarter ended June 2023 of Rs. 125.81 millions rose by 26.86% from Rs. 99.17 millions.The Company's Net profit for the June 2023 quarter have declined marginally to Rs. 15.49  millions as against Rs. 17.97 millions reported during the corresponding quarter ended.Operating Profit reported a sharp decline to 20.71 millions from 22.74 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 125.81 99.17 26.86 125.81 99.17 26.86 354.92 306.13 15.94
Other Income 0.60 1.17 -48.72 0.60 1.17 -48.72 5.54 2.43 127.98
PBIDT 20.71 22.74 -8.93 20.71 22.74 -8.93 61.90 59.69 3.70
Interest 0.43 0.74 -41.89 0.43 0.74 -41.89 3.59 2.13 68.54
PBDT 20.28 22.00 -7.82 20.28 22.00 -7.82 58.31 57.56 1.30
Depreciation 2.29 2.17 5.53 2.29 2.17 5.53 8.88 8.77 1.25
PBT 17.99 19.83 -9.28 17.99 19.83 -9.28 49.43 48.79 1.31
TAX 2.50 1.86 34.41 2.50 1.86 34.41 4.33 0.32 1253.13
Deferred Tax 0.00 -0.64 -100.00 0.00 -0.64 -100.00 -6.10 0.32 -2006.25
PAT 15.49 17.97 -13.80 15.49 17.97 -13.80 45.10 48.47 -6.95
Equity 99.98 99.98 0.00 99.98 99.98 0.00 99.98 99.98 0.00
PBIDTM(%) 16.46 22.93 -28.21 16.46 22.93 -28.21 17.44 19.50 -10.55
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..